Business Vision
Daktari Biotechnology aims to drive innovations and bridge gaps to transform patients’ lives through making Africa sufficient in Biologics and Pharmaceuticals.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with LaserArt Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Complete
Preclinical to be started.
Produced with Bacman Technology.
Research Ongoing
Preclinical to be started.
Daktari Biotechnology aims to drive innovations and bridge gaps to transform patients’ lives through making Africa sufficient in Biologics and Pharmaceuticals.
Daktari Biotechnology is a pioneering, patient-centric biotechnology firm with a dynamic and innovative spirit that aims to address the profound health challenges facing people in Africa and around the world. By driving groundbreaking innovations and bridging critical gaps in healthcare, we strive to transform the lives of patients. Empowered by a commitment to excellence and guided by a deep sense of ethical responsibility, we work to develop therapies and solutions that not only treat illnesses but also significantly enhance the quality of life. Our mission extends beyond scientific discovery; we are dedicated to serving communities by providing unencumbered access to advanced healthcare products, nurturing a compassionate ecosystem that supports patient health, and promoting overall well-being.
Be the Premier Bio-Pharmaceutical Company in this business Space/Niche in Africa’s Market
At Daktari Biotechnology, our core values—Integrity, Bravery, Compassion, Stewardship, and Humanity—define our commitment to ethical excellence, innovative solutions, community empowerment, sustainable practices, and social responsibility. These principles drive us to transform healthcare and foster lasting, positive change across Africa.
Integrity in Daktari Biotechnology encapsulates uncompromising adherence to ethical standards and transparent governance, fostering trust and moral accountability in every facet of our work. By ensuring decisions and actions are ethically sound and transparent, we build trust with our stakeholders, which is crucial for sustainable success in the pharmaceutical industry.
Bravery at Daktari Biotechnology is our catalyst for innovation and collaborative strength, driving us to pioneer life-saving medicines and create symbiotic partnerships. It allows us to push beyond conventional boundaries, fostering advancements and strategic collaborations that are key to solving complex health challenges.
Compassion is the heartbeat of our community engagement and educational endeavors, guiding us to meet immediate health needs and empower through knowledge. Compassion leads to tangible health improvements and informed communities, enhancing the impact of biotechnology on individual lives and societal health.
Stewardship in Daktari Biotechnology means advancing sustainable and resilient practices to ensure our health solutions are environmentally conscious and enduring. Robust sustainability practices ensure we meet today’s health needs without compromising future generations, essential in the face of global environmental challenges.
Humanity reflects our dedication to social responsibility, driving us to improve health outcomes through ethical practices and a commitment to global and community welfare. By prioritizing humanity in our operations, we address essential health disparities and contribute to the socio-economic development of the communities we serve.
The objectives set by DKTB are ambitious yet attainable, reflecting a clear understanding of the market, resources, and external environment. With a robust operational framework, experienced leadership, and strategic location, the company is well-positioned to meet these targets. These goals follow the SMART criteria—Specific, Measurable, Achievable, Relevant, and Time- bound—ensuring focused, structured growth.
The first products for production for humans will be long-acting antiretroviral pharmaceuticals targeting both HIV & Hepatitis, a long-acting anti-TB pharmaceutical, a long-acting anti-Malaria pharmaceutical and insulin biologic biosimilar (short and eventually long-acting insulin) in the human disease space.
In the animal health care space, a Foot and Mouth Disease Virus (FMDV) and New Castle Disease Virus (NCDV) vaccines as well as long-acting pharmaceutical(s) to treat East Coast Fever for livestock are also being developed.
These will be followed by the production of at least 2-dozen more novel or reformulated biopharmaceuticals over the years that address the needs in human and animal health care space.
Daktari Biotechnology will target and harness technology as well as professional expertise from Kenyans/Africans living abroad and other partners. The company will establish the research, production and regulatory capacity required to successfully develop the relevant small molecule pharmaceuticals, biologics, biosimilars or reformulated medicines.
Daktari Biotechnology Limited is one of the Diaspora University Town development plans for jobs creation, housing development and Gross Domestic Product (GDP) growth. The company’s medicine and vaccine plant are progressing to be set up at Diaspora University Town in Taita Taveta County in Kenya. The plant has been allocated 11 acres of land. The design of the building is completed and the Environmental Social and Impact Assessment (ESIA) is progressing. Outlined below are the short-term and long- term goals planned for DKTB:
DKTB offerings in animal health care span a diverse range of therapeutics that includes small molecule pharmaceuticals and vaccines specifically developed to combat the high prevalence of infectious, protozoan and parasitic diseases across the continent. DKTB addresses crucial animal health concerns by developing laser art and vaccines products to treat and prevent diseases such as East Coast Fever, New Castle Disease and Foot and Mouth Disease, which significantly impact livestock health and the agricultural economy in Africa. A Laser art product for treat East Coast fever and vaccines against foot and mouth disease, and new castle disease viruses are currently being developed.
DKTB animal vaccines have been designed to be produced as virus-like particles (VLPs) that holds numerous advantages over traditional methods: Leveraging VPLs Safety because VLPs lack viral nucleic acid, mitigating replication and reversion risks associated with whole-virus vaccines, thereby ensuring safety.
Each product is meticulously designed with the region’s unique healthcare requirements in mind, prioritizing efficacy, safety, affordability, and accessibility to deliver impactful, life-saving solutions.